Carmen Ferrajolo

2.4k citations
56 papers · 1.4k indexed · h-index 24
Topics
Pharmaceutical studies and practices (15 papers)Pharmacovigilance and Adverse Drug Reactions (13 papers)Pharmaceutical Practices and Patient Outcomes (6 papers)
Partner nations
ItalyNetherlandsCanada

In The Last Decade

Carmen Ferrajolo

54 papers receiving 1.4k citations

Peers

Carmen Ferrajolo
Comparison fields: 5 of 111
  • Toxicology 266
  • Pediatrics, Perinatology and Child Health 258
  • Nephrology 216
  • Surgery 201
  • Molecular Biology 175
Replace Daniel R. Morales with:
Daniel R. Morales United Kingdom
Xavier Carné Spain
Consuelo Huerta Spain
Hitomi Teramachi Japan
Liberata Sportiello Italy
Rita Schinnar United States
Jung Mi Oh South Korea
Eric N. van Roon Netherlands
Charles E. Leonard United States
Matthew A. Weir Canada
Carmen Ferrajolo relative to Daniel R. Morales United Kingdom Daniel R. Morales's profile →
Citations per field
00.5×1.5×2.4×
Daniel R. Morales · 1×
Citations per year

Countries citing papers authored by Carmen Ferrajolo

Since Specialization
Citations

This map shows the geographic impact of Carmen Ferrajolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Ferrajolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Ferrajolo more than expected).

Fields of papers citing papers by Carmen Ferrajolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Ferrajolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Ferrajolo. The network helps show where Carmen Ferrajolo may publish in the future.

Co-authorship network of co-authors of Carmen Ferrajolo

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Ferrajolo. A scholar is included among the top collaborators of Carmen Ferrajolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Ferrajolo. Carmen Ferrajolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 1
3 33
4 10
5 32
6 7
7 68
8 34
9 2
10 3
11 20
12 20
13 22
14 28
15 29
16 18
17 19
18 30
19 223
20 53

About Carmen Ferrajolo

Carmen Ferrajolo is a scholar working on Toxicology, Geriatrics and Gerontology and Applied Microbiology and Biotechnology, having authored 56 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (15 papers), Pharmacovigilance and Adverse Drug Reactions (13 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). The work is most often cited by research in Toxicology (266 citations), Nephrology (216 citations) and Geriatrics and Gerontology (87 citations). Carmen Ferrajolo has collaborated with scholars based in Italy, Netherlands and Canada. Frequent co-authors include Gianluca Trifirò, Annalisa Capuano, Concetta Rafaniello, Giampiero Mazzaglia, Claudio Cricelli, Achille P. Caputi, Miriam Sturkenboom, Cristina Scavone, Janet Sultana and Elisa Bianchini. Their work appears in journals such as PLoS ONE, Annals of the Rheumatic Diseases and Pharmacological Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026